ASCO GI 2021 | Highlights in HCC from ASCO GI 2021

Jean-Luc Van Laethem, MD, PhD, Erasme Hospital University, Brussels, Belgium, outlines updates in hepatocellular carcinoma (HCC), including results from the IMBrave study, as well as the use of systemic therapies in combination with localized approaches. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).